Senior insider sale
Chief Executive Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$7.28M
206.50K shares
What this filing means
DUBE ERIC M plans to sell 206.50K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $7.28M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/6/2026ACC: 0001959173-26-003309
DirectorOfficer· Chief Executive Officer
Since Jan 2019
206.50K
Shares to sell
$7.28M
Approx. market value
22.50K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/4/2026
22.50KTotal acquired22.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Restricted Stock Vesting Compensation | 22.50K | — |
| Total | 22.50K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
64K
Market value
$2.63M
4/15/2026
—Completed
Units to sell
60K
Market value
$1.86M
4/1/2026
—Completed
Units to sell
60K
Market value
$1.81M
2/20/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
22.50K
Market value
$988.9K
5/6/2026
Total
Units
206.50K
Value
$7.28M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/15/2026 | 64K | $2.63M | — | Completed |
4/1/2026 | 60K | $1.86M | — | Completed |
2/20/2026 | 60K | $1.81M | — | Completed |
| Planned — Approximate Date | ||||
5/6/2026 | 22.50K | $988.9K | NASDAQ | Planned |
| Total | 206.50K | $7.28M | ||